Gland Pharma is currently trading at Rs. 1587.75, up by 6.40 points or 0.40% from its previous cl...
Indian generic injectables maker Gland Pharma Ltd reported a 41% jump in first-quarter revenue on...
BENGALURU - Indian generic injectables maker Gland Pharma Ltd reported a 56% decline in fourth-qu...
BENGALURU -Shares of India's Mankind Pharma Ltd ended with gains of 31.7% in their trad...
China's Shanghai Fosun Pharmaceutical Group Co Ltd has withdrawn plans to sell stake in India...
Gland Pharma on Monday announced that it will invest over Rs 400 crore in Hyderabad's G...
Gland Pharma is currently trading at Rs. 1424.30, up by 67.30 points or 4.96% from its previous c...
Long road to recovery Result Synopsis Gland reported a weak quarter on back of declines in ...
Gland Pharma is currently trading at Rs. 1584.50, up by 7.50 points or 0.48% from its previous cl...
Indian generic injectables maker Gland Pharma Ltd said on Tuesday it will buy privately held Fren...
India and ROW hurt earnings Work in progress for product pipeline/newer markets/streamlining o...
Key News IDBI Bank's Q1 net rises 25% to Rs 756 cr as provisions, contingencies dip Pr...
A forgettable quarter; all eyes on revenue recovery Result Synopsis Company expec...
Multiple levers at play; valuations attractive * After delivering 27% earnings CAGR over ...
Well-placed to gain from the drug shortages in the US Compliance/manufacturing scale-up offers...
Earnings growth momentum in sustainable mode On track to build complex product pipeline * G...
Growth outlook intact Our view Gland clocked yet another healthy topline quarter with US gr...
An evolving injectable franchise * A robust revenue performance allays any concerns on growth ...
Gland Pharma is currently trading at Rs. 3737.00, up by 92.20 points or 2.53% from its previous c...
Gland Pharma is currently trading at Rs. 3585.55, up by 55.25 points or 1.57% from its previous c...
NDR takeaways: The ‘flywheel effect’ in motion * We hosted Gland Pharma management...
Revenue traction intact; BUY stays Our view Gland Pharma clocked yet another strong revenue...
Below is quote on Gland Pharma reported Q2FY22 numbers in line with market expectation ...
Below are Views On Future-ready CDMO player with eyes on the Biosimilar market By Mr. Sriniv...
Expanding niche portfolio/reach * Its core markets (US, Europe, Canada, and Australia) are exp...
Complex products/newer markets to fortify growth pace Progressing well on scaling up manufactu...
Below is quote on Gland pharma reported a good set of numbers for Q1FY22 by M...
Our view A 30% revenue growth quarter should uniformly boost confidence and bolsters our belie...
Key News Bharti Airtel-Intel network deal to speed up 5G service roll-out Bharti Airtel on ...
Building multiple levers to sustain the growth momentum Margin surprise in 4QFY21 led by produ...
Below are Quote on Gland Pharma - 4QFY21 by Mr. Yash Gupta Equity...
Result Highlights * Revenues jumped ~40% YoY on the back of strong growth in core markets (US ...
Key News Colgate-Palmolive India Q4 net profit jumps 54% to Rs 314.6 crore Consumer goods m...
* Stock moving northwards in its standard pattern of breakout retest as we can see on charts. ...
Gland Pharma is currently trading at Rs. 2725.80, up by 67.85 points or 2.55% from its previous c...
BENGALURU - Gland Pharma Ltd said on Tuesday it had struck a deal with the Russian Direct Investm...
BENGALURU - Shares of India's Gland Pharma got off to a flying start in their market de...
Below are Quote on Gland Pharma IPO By Mr. Yash Gupta- Equity Research Associate, Angel...
Gland Pharma Ltd. has announced public offering of 43196968 shares at a price of Rs 1.00 each for...